Sanofi SA vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $32.34. The key difference: Sanofi SA pays a 5.5% dividend while Direxion Daily 20 Year Treasury Bull 3X Shares pays none, and Sanofi SA is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| SNY | TMF | |
|---|---|---|
Market Cap | $104.83B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $52.34 | $44.14 |
52-Week Low | $41.33 | $31.85 |
Enterprise Value | $121.32B | — |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →